The abstract is read at the publisher; the summary is JClub's.
Intranasal HA Stalk-Fc vaccination in mice provides significant protection against H1N1, H5N1, H6N2, and H9N2, with reduced viral replication in nasal turbinates and lungs.
- Why it matters: Universal nasal vaccines are needed to counter influenza’s antigenic drift and shift by generating durable respiratory-tract immunity. The study targets FcRn-mediated IgG transport across the epithelial barrier.
- What they did: Mice received intranasal Stalk-Fc, a monomeric IgG Fc fused to a prefusion-modified HA Stalk, to elicit mucosal and systemic responses. Immune readouts included nasal/airway/blood antibodies, lung tissue-resident memory T cells, and bone-marrow long-lived plasma cells.
- The result: Stalk-Fc induced long-lasting HA Stalk-specific IgA and IgG and cross-reactive functional activity, linked to lower viral replication and broad subtype protection. The findings support FcRn-facilitated delivery as a basis for a universal influenza nasal vaccine.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.